The equity awards were granted pursuant to the Company's 2020 Inducement Plan, which was approved by the Company's Board of Directors in
About
Contact:
Tel: (650) 922-1269
Email: hkolkey@arcusbio.com
(C) 2023 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.89 USD | +3.05% | +12.86% | -16.81% |
07-09 | Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan | MT |
07-05 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
The equity awards were granted pursuant to the Company's 2020 Inducement Plan, which was approved by the Company's Board of Directors in
About
Contact:
Tel: (650) 922-1269
Email: hkolkey@arcusbio.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-16.81% | 1.4B | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |